This webinar covers

The immune tolerance landscape is nothing but dynamic; in our recent webinar, our expert panel discussed the obstacles in treating autoimmune diseases with T Cell therapy approaches and the strategies the developers are utilizing to overcome these obstacles. Key aspects explored included:

    • A comprehensive overview of the competitive T Cell therapy within the immune-mediated disease space
    • Insights into the emerging trends of Treg therapies
    • A picture of what we can likely expect ahead based on recent approvals and late-stage activity
Hosted by


Webinar Leaders

House Speaker

Rachel Hourigan
Immune Tolerance Lead Research Analyst


Luka Vukoje
Account Manager

Speak with our team about Beacon Immune Tolerance

What is Beacon Immune Tolerance?


Beacon Immune Tolerance covers all pharmaceutical interventions used to treat autoimmune diseases, autoinflammatory diseases, alloimmune diseases, and allergies.

From small molecules to CAR T therapy, the module encapsulates all drugs and therapies within the immune-mediated disease space. The database currently houses:

  • 4200+ drugs, including 2500+ clinically active and 1500+ preclinical
  • 9500+ trials overall, 900+ are active but not recruiting
  • 5000+ companies involved in developing therapies for immune-mediated diseases


Find out more

How Beacon Immune Tolerance works


All Immune Tolerance pages will have unique data fields that will help speed up the research process. These data fields include:

  • Autoantigen specificity
  • Mechanism of Action
  • Cell Source
  • Cell Type
  • Delivery System
  • Editing Technology
  • Target Organ/Cell
  • Formulation

Our unique Milestones filter and visualization highlights past, present, and future drug development milestones including drug and trial readouts, asset history, and regulatory announcements. This enhancement provides an accurate, timely and exhaustive single-drug timeline allowing you to benchmark progress in the immune tolerance space.

Contact Us

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more